EVH Insider Trading

Insider Ownership Percentage: 1.60%
Insider Buying (Last 12 Months): $666,315.20
Insider Selling (Last 12 Months): $9,290,384.77

Evolent Health Insider Trading History Chart

This chart shows the insider buying and selling history at Evolent Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$666kbought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M-$5M$0$5M$10MTotal Insider BuyingTotal Insider Selling

Evolent Health Share Price & Price History

Current Price: $9.44
Price Change: Price Decrease of -0.104 (-1.09%)
As of 03/14/2025 04:59 PM ET

This chart shows the closing price history over time for EVH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$9.51Closing price on 03/13/25:

SEC Filings (Institutional Ownership Changes) for Evolent Health (NYSE:EVH)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EVH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$176Mbought$170MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100M$0$100MTotal InflowsTotal Outflows
Evolent Health logo
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Read More on Evolent Health

Today's Range

Now: $9.44
Low: $9.40
High: $9.80

50 Day Range

MA: $10.22
Low: $8.58
High: $12.61

52 Week Range

Now: $9.44
Low: $8.35
High: $33.63

Volume

5,867,410 shs

Average Volume

2,102,971 shs

Market Capitalization

$1.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of Evolent Health?

Evolent Health's top insider shareholders include:
  1. Frank J Williams (Director)
  2. Seth Blackley (CEO)
  3. Daniel Joseph Mccarthy (President)
  4. John Paul Johnson (CFO)
  5. Jonathan Weinberg (General Counsel)
  6. Diane Holder (Director)
  7. Emily Ann Rafferty (COO)
  8. Cheryl Scott (Director)
  9. Brendan B Springstubb (Director)
Learn More about top insider investors at Evolent Health.

Who are the major institutional investors of Evolent Health?

Evolent Health's top institutional shareholders include:
  1. Vanguard Group Inc. — 9.58%
  2. Wellington Management Group LLP — 8.95%
  3. Engaged Capital LLC — 4.64%
  4. Cadian Capital Management LP — 4.48%
  5. William Blair Investment Management LLC — 4.10%
  6. Granahan Investment Management LLC — 3.15%
Learn More about top institutional investors of Evolent Health stock.

Which institutional investors are selling Evolent Health stock?

During the previous quarter, EVH stock was sold by these institutional investors:
  1. RA Capital Management L.P.
  2. First Light Asset Management LLC
  3. Wellington Management Group LLP
  4. Bellevue Group AG
  5. American Century Companies Inc.
  6. Point72 Asset Management L.P.
  7. Franklin Resources Inc.
  8. Farallon Capital Management LLC
During the previous year, company insiders that have sold Evolent Health company stock include:
  1. Frank J Williams (Director)
  2. Seth Blackley (CEO)
  3. Daniel Joseph Mccarthy (President)
  4. John Paul Johnson (CFO)
  5. Jonathan Weinberg (General Counsel)
Learn More investors selling Evolent Health stock.

Which institutional investors are buying Evolent Health stock?

In the last quarter, EVH stock was bought by institutional investors including:
  1. Cadian Capital Management LP
  2. Engaged Capital LLC
  3. Boston Partners
  4. Norges Bank
  5. Sea Cliff Partners Management LP
  6. Millennium Management LLC
  7. Barclays PLC
  8. Hudson Bay Capital Management LP
In the last year, these company insiders have bought Evolent Health stock:
  1. Frank J Williams (Director)
  2. Seth Blackley (CEO)
  3. Daniel Joseph Mccarthy (President)
  4. John Paul Johnson (CFO)
Learn More investors buying Evolent Health stock.